Prospective analysis of disability and quality of life in patients with chronic inflammatory demyelinating polyradiculoneuropathy
Tóm tắt
Từ khóa
Tài liệu tham khảo
Van den Bergh, P. Y. K., Hadden, R. D. M., Bouche, P., Cornblath, D. R., Hahn, A., Illa, I., et al. (2010). European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripher. European Journal of Neurology, 17(3), 356–363.
Mayo, E. N. (2015). ISOQOL dictionary of quality of life and health outcomes measurement. International Society for Quality of Life Research.
Bozovic, I., Kacar, A., Peric, S., Nikolic, A., Bjelica, B., Cobeljic, M., et al. (2017). Quality of life predictors in patients with chronic inflammatory demyelinating polyradiculoneuropathy. Journal of Neurology, 264(12), 2481–2486.
Merkies, I. S., Schmitz, P. I., van der Meché, F. G., Samijn, J. P., van Doorn, P. A., & Inflammatory Neuropathy Cause and Treatment (INCAT) group. (2002). Quality of life complements traditional outcome measures in immune-mediated polyneuropathies. Neurology, 59(1), 84–91.
Harbo, T., Andersen, H., Overgaard, K., & Jakobsen, J. (2008). Muscle performance relates to physical function and quality of life in long-term chronic inflammatory demyelinating polyradiculoneuropathy. Journal of the Peripheral Nervous System, 13(3), 208–217.
Westblad, M. E., Forsberg, A., & Press, R. (2009). Disability and health status in patients with chronic inflammatory demyelinating polyneuropathy. Disability and Rehabilitation, 31(9), 720–725.
Erdmann, P. G., van Meeteren, N. L. U., Kalmijn, S., Wokke, J. H. J., Helders, P. J. M., & van den Berg, L. H. (2005). Functional health status of patients with chronic inflammatory neuropathies. Journal of the Peripheral Nervous System, 10(2), 181–189.
dos Santos, P. L., de Almeida-Ribeiro, G. A. N., Silva, D. M. D., Marques Junior, W., & Barreira, A. A. (2014). Chronic inflammatory demyelinating polyneuropathy: Quality of life, sociodemographic profile and physical complaints. Arquivos de Neuro-Psiquiatria, 72(3), 179–183.
Merkies, I. S. J., & Kieseier, B. C. (2016). Fatigue, pain, anxiety and depression in Guillain-Barré Syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. European Neurology, 75(3–4), 199–206.
Goebel, A., Lecky, B., Smith, L. J., & Lunn, M. P. (2012). Pain intensity and distribution in chronic inflammatory demyelinating polyneuropathy. Muscle and Nerve, 46(2), 294–295.
Kacar, A., Bjelica, B., Bozovic, I., Peric, S., Nikolic, A., Cobeljic, M., et al. (2018). Neuromuscular disease-specific questionnaire to assess quality of life in patients with chronic inflammatory demyelinating polyradiculoneuropathy. Journal of the Peripheral Nervous System, 23(1), 11–16.
Merkies, I. S., Bril, V., Dalakas, M. C., Deng, C., Donofrio, P., Hanna, K., et al. (2009). Health-related quality-of-life improvements in CIDP with immune globulin IV 10%: The ICE Study. Neurology, 72(15), 1337–1344.
Kleyweg, R. P., van der Meché, F. G., & Schmitz, P. I. (1991). Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. Muscle and Nerve, 14(11), 1103–1109.
Breiner, A., Barnett, C., & Bril, V. (2014). INCAT disability score: A critical analysis of its measurement properties. Muscle and Nerve, 50(2), 164–169.
http://www.qualitymetric.com SF-36 Health Survey (Original version) Language Recalls.
Cohen, J. (1960). A coefficient of agreement for nominal scales. Educational and Psychological Measurement, 20, 37–46.
Bjelica, B., Peric, S., Bozovic, I., Kacar, A., Cobeljic, M., Dejanovic, I., et al. (2019). One-year follow-up study of neuropathic pain in chronic inflammatory demyelinating polyradiculoneuropathy. Journal of the Peripheral Nervous System, 24(2), 180–186.
Gable, K. L., Attarian, H., & Allen, J. A. (2020). Fatigue in chronic inflammatory demyelinating polyneuropathy. Muscle and Nerve. https://doi.org/10.1002/mus.27038.
Merkies, I. S. J., van Nes, S. I., Hanna, K., Hughes, R. A. C., & Deng, C. (2010). Confirming the efficacy of intravenous immunoglobulin in CIDP through minimum clinically important differences: Shifting from statistical significance to clinical relevance. Journal of Neurology, Neurosurgery and Psychiatry, 81(11), 1194–1199.
Lawley, A., Abbas, A., Seri, S., & Rajabally, Y. A. (2020). Clinical correlates of fatigue in chronic inflammatory demyelinating polyneuropathy. Muscle and Nerve, 62(2), 226–232.